Aeolus Pharmaceuticals, Inc. (AOLS)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jun 5, 2025
Aeolus Pharmaceuticals Revenue
Aeolus Pharmaceuticals had revenue of $13.00K in the quarter ending June 30, 2017, a decrease of -98.03%. This brings the company's revenue in the last twelve months to $771.00K, down -68.71% year-over-year. In the fiscal year ending September 30, 2016, Aeolus Pharmaceuticals had annual revenue of $2.08M, down -33.27%.
Revenue (ttm)
771.00K
Revenue Growth
-68.71%
P/S Ratio
0.02
Revenue / Employee
192.75K
Employees
4
Market Cap
15.21K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2016 | 2.08M | -1.04M | -33.27% |
Sep 30, 2015 | 3.11M | -6.52M | -67.70% |
Sep 30, 2014 | 9.63M | 5.70M | 145.19% |
Sep 30, 2013 | 3.93M | -3.37M | -46.14% |
Sep 30, 2012 | 7.29M | 2.47M | 51.28% |
Sep 30, 2011 | Pro | Pro | Pro |
Sep 30, 2010 | Pro | Pro | Pro |
Sep 30, 2009 | Pro | Pro | Pro |
Sep 30, 2008 | Pro | Pro | Pro |
Sep 30, 2007 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |